SCHEMBL8934577

SCHEMBL8934577

CNC(=S)Nc1ccc(-c2cc3ccccc3oc2=O)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.68
GAA P10253 2/20 0.68
RAB9A P51151 6/20 0.67
SMN1; SMN2 Q16637 6/20 0.67
KDM4E B2RXH2 5/20 0.67
NPC1 O15118 5/20 0.67
MAPT P10636 4/20 0.64
HPGD P15428 3/20 0.59
NCOA1 Q15788 2/20 0.59
GAPDH P04406 2/20 0.59
NCOA3 Q9Y6Q9 1/20 0.59
ESR1 P03372 1/20 0.59
ESR2 Q92731 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
MAOB P27338 2/20 0.57
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
GLA P06280 1/20 0.56
PPARG P37231 1/20 0.56
NCOA2 Q15596 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13757026 0.85 ALDH1A1 (0.67) ALDH1A1GAARAB9ASMN1; SMN2KDM4E
SCHEMBL13757025 0.83 ALDH1A1 (0.75) ALDH1A1GAARAB9ASMN1; SMN2KDM4E
SCHEMBL19003439 0.83 ALDH1A1 (0.69) ALDH1A1GAARAB9ASMN1; SMN2KDM4E
SCHEMBL8447062 0.79 ALDH1A1 (0.69) ALDH1A1GAARAB9ASMN1; SMN2KDM4E
SCHEMBL8934579 0.78 ALDH1A1 (0.67) ALDH1A1GAARAB9ASMN1; SMN2KDM4E
SCHEMBL12387899 0.76 ALDH1A1 (0.69) ALDH1A1GAARAB9ASMN1; SMN2KDM4E
SCHEMBL13757027 0.75 ALDH1A1 (0.61) ALDH1A1GAARAB9ASMN1; SMN2KDM4E
SCHEMBL30096432 0.75 NCOA1 (1.00) ALDH1A1GAARAB9ASMN1; SMN2KDM4E
SCHEMBL4064740 0.75 ALDH1A1 (1.00) ALDH1A1GAARAB9ASMN1; SMN2KDM4E
SCHEMBL14389070 0.75 MAOB (0.75) ALDH1A1GAARAB9ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 WO disclosed